| Literature DB >> 32624187 |
Filippo Sanfilippo1, Stefano Tigano2, Gaetano J Palumbo3, Marinella Astuto2, Paolo Murabito2.
Abstract
Entities:
Keywords: laryngeal mask airway; manikin; pandemic; personal protective equipment; tracheal intubation; videolaryngoscope
Mesh:
Year: 2020 PMID: 32624187 PMCID: PMC7293489 DOI: 10.1016/j.bja.2020.06.011
Source DB: PubMed Journal: Br J Anaesth ISSN: 0007-0912 Impact factor: 9.166
Characteristics of included studies in the systematic review on simulation of airway management with participants wearing personal protective equipment (PPE). ∗National Health Service standardised CBRN-PPE (Respirex Internal Systems, Surrey, UK; and 3M United Kingdom plc, Bracknell, UK), which is a fully encapsulated suit incorporating a panoramic visor to improve vision but which retains the thick ‘rubber’ gloves that adversely affect fine motor skills. †DuPont (Wilmington, DE, USA) protective clothing (Tychem CPF3 and Tyvek suits), butyl rubber gloves, boots, and PA301S Powered Air Purifying Respirators (Bullard, Cynthiana, KY, USA). ‡Two pairs of gloves (Biogel® Indicator® Underglove; Mölnlycke Health Care, Schlieren, Switzerland; Sempermed® supreme surgical gloves sterile; Semperit AG, Vienna, Austria), chemical protective clothing (Tychem C™ with socks; DuPont), a hard hat (Versaflo™S-605-10; 3M Corp., St. Paul, MN, USA), and a respirator and 23 a Powered Air Purifying Respirator (PAPR) (Jupiter™ Powered Air Turbo Unit; 3M™; MN, USA). ¶Nylon shirt and pants (DuPont Tychem BR), antigas mask with active filter (3M Full-Facepiece 6800 DIN Respirator, Medium; 3M Corp.), gloves (North By Honeywell B324/9) and rubber boots HAZMAX Regular Steel Toe Boots). ||Tychem F CPF 2 (DuPont, Wilmington, DE, USA) encapsulating suit, Breathe Easy Butyl Hood System (3M Corp.; Maplewood, MN, USA) hooded powered air-purifying respirator (PAPR), nitrile gloves (Thermo Fisher Scientific, Waltham, MA, USA), and Ongard Boots (Thermo Fisher Scientific) as PPE. # Powered Air-Purifying Respirator, 3M Scott Safety Ltd, West Pimbo, Skelmersdale, UK. ∗∗ FRR, 3M Scott Safety Ltd, West Pimbo, Skelmersdale, UK. Airtraq IL: Indirect Laryngoscopy with standard Airtraq TM (size green, using the eyepiece); CI, confidence interval; DL: Direct Laryngoscopy. I-LMA: Intubating-Laryngeal Mask Airway; IQR, inter-quartile range; LMA: laryngeal mask airway; sd, standard deviation; VL: Video-laryngoscopy. In response to the letter by Sorbello and colleagues accepted during the Advance Access prepublication stage, the table was updated with one additional study. This did not affect the overall findings, but the table was updated in proof stage for completeness.
| Authors, journal, year | Design of study | Manikin, airway | Population, | Devices | Outcomes of airways management wearing PPE | ||||
|---|---|---|---|---|---|---|---|---|---|
| Successful attempts (success rate) | Time (s) to | ||||||||
| <60 s | <120 s (overall) | Placement success, mean ( | |||||||
| Castle and colleagues, | Randomised, crossover | Laerdal Advanced Airway Trainer, | 58 paramedics students, CBRN-PPE¹* | LMA | 47/58 (81%) | 58/58 (100%) | 48 (18) | ||
| ProSeal | 52/58 (90%) | 57/58 (98%) | 44 (16) | ||||||
| i-gel | 58/58 (100%) | 58/58 (100%) | 19 (8) | ||||||
| Laringeal tube | 55/58 (95%) | 58/58 (100%) | 38 (13) | ||||||
| Combitube | 25/58 (43%) | 55/58 (95%) | 65 (23) | ||||||
| LMA-Fastrach | 43/58 (74%) | 58/58 (100%) | 51 (18) | ||||||
| Time unspecified | Intubation success, mean (95% CI) | ||||||||
| Yousif and colleagues, | Prospective, randomised, crossover | Laerdal Resusci-Anne manikin system, | 20 prehospital providers | DL | 19/20 (95%) | 28 (22–29) | |||
| Glidescope VL | 20/20 (100%) | 36 (3240) | |||||||
| KingVision VL | 20/20 (100%) | 30 (26–43) | |||||||
| <240 s (overall) | Ventilation success, mean (IQR) | ||||||||
| Plazikowski and colleagues, | Randomised, controlled | Laerdal Airway | 30 anaesthesiologists | i-gel | 30/30 (100%) | 10 (8–11) | |||
| LMA-Fastrach | 30/30 (100%) | 10 (8–12) | |||||||
| DL | 30/30 (100%) | 24 (20–29) | |||||||
| Airtraq VL | 27/30 (90%) | 29 (23–48) | |||||||
| Ambu fiberoptic-aScope | 29/30 (97%) | 51 (40–88) | |||||||
| Melker cricothyrotomy set | 30/30 (100%) | 58 (45–69) | |||||||
| <60 s | <120 s | <150 s (overall) | Intubation success, mean ( | ||||||
| Castle and colleagues, | Randomised, crossover | Laerdal Advanced Airway trainer™, | 66 paramedic students, | DL | 50/66 (76%) | 60/66 (91%) | 61/66 (92%) | 50 (21) | |
| DL with stylet | 48/66 (73%) | 61/66 (92%) | 61/66 (92%) | 51 (17) | |||||
| DL with Bougie | 38/66 (58%) | 60/66 (91%) | 61/66 (92%) | 58 (20) | |||||
| DL with McCoy | 46/66 (70%) | 53/66 (80%) | 54/66 (82%) | 51 (16) | |||||
| Airtraq VL | 33/66 (50%) | 53/66 (80%) | 56/66 (85%) | 70 (38) | |||||
| I-LMA | 39/66 (59%) | 63/66 (95%) | 64/66 (97%) | 61 (20) | |||||
| <60 s (overall) | Intubation success (mean) | ||||||||
| Wedmore and colleagues, | Prospective, observational | Laerdal intubating head manikin, | 16 EM residents with prior airway experience, | DL | 25/32 (78%) | 29 | |||
| I-LMA | 32/32 (100%) | 25 | |||||||
| <120 s (overall) | Intubation success, mean (IQR) | ||||||||
| Shin and colleagues, | Randomised, crossover | Laerdal Airway | 31 medical doctors (19 with prior intubation experience) | DL with stylet | 30/31 (97%) | 26 (23–35) | |||
| Pentax-AWS VL | 31/31 (100%) | 18 (15–22) | |||||||
| Time unspecified | Ventilation success, mean ( | ||||||||
| Aberle and colleagues, | Randomised, crossover | SimMan 3G, | 21 EM residents, | DL | 20/21 (95%) | 10 (5) | |||
| GlideScope Cobalt VL | 21/21 (100%) | 8 (3) | |||||||
| Time unspecified | To intubation success, mean (±SD) | ||||||||
| Powered respirator | Standard respirator | ||||||||
| Randomised, crossover | Laerdal Airway Management TrainerTM, | 25 anesthesiologists, | DL | 25/25 (100%) | 16 (6) | 15.1 (5) | |||
| Airtraq IL | 25/25 (100%) | 169 | 19.2 (5) | ||||||
| Airtraq VL | 25/25 (100%) | 11 (3) | 10.0 (2) | ||||||
| Ambu A/S | 25/25 (100%) | 39 (4) | 40.1 (5) | ||||||